12 August 2015
A dispatch from our Washington correspondent on the sluggish progress of the 21st Century Cures Act.
Republicans and Democrats in the U.S. House of Representatives last month overwhelmingly passed the 21st Century Cures Act aimed at speeding up drug development. But the Senate is not expected to vote on its version until next year.
More than 80 percent of the House backed the legislation after it was unanimously — a word rarely heard on Capitol Hill — approved by the House Committee on Energy and Commerce. In the process, the bill was revised to address concerns that drug approvals would happen a little too quickly, circumventing safety and efficacy standards. [Continued here]
(Visited 40 times, 1 visits today)